208 related articles for article (PubMed ID: 30251762)
1. Self-emulsifying drug delivery systems and cationic surfactants: do they potentiate each other in cytotoxicity?
Lam HT; Le-Vinh B; Phan TNQ; Bernkop-Schnürch A
J Pharm Pharmacol; 2019 Feb; 71(2):156-166. PubMed ID: 30251762
[TBL] [Abstract][Full Text] [Related]
2. Highly mucus permeating and zeta potential changing self-emulsifying drug delivery systems: A potent gene delivery model for causal treatment of cystic fibrosis.
Griesser J; Hetényi G; Federer C; Steinbring C; Ellemunter H; Niedermayr K; Bernkop-Schnürch A
Int J Pharm; 2019 Feb; 557():124-134. PubMed ID: 30594687
[TBL] [Abstract][Full Text] [Related]
3. Mucolytic self-emulsifying drug delivery systems (SEDDS) containing a hydrophobic ion-pair of proteinase.
Lam HT; Le NN; Phan TNQ; Bernkop-Schnürch A
Eur J Pharm Sci; 2021 Jul; 162():105658. PubMed ID: 33271277
[TBL] [Abstract][Full Text] [Related]
4. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
[TBL] [Abstract][Full Text] [Related]
5. Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation.
Suchaoin W; Pereira de Sousa I; Netsomboon K; Lam HT; Laffleur F; Bernkop-Schnürch A
Int J Pharm; 2016 Aug; 510(1):255-62. PubMed ID: 27329673
[TBL] [Abstract][Full Text] [Related]
6. Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration.
Zupančič O; Grieβinger JA; Rohrer J; Pereira de Sousa I; Danninger L; Partenhauser A; Sündermann NE; Laffleur F; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2016 Dec; 109():113-121. PubMed ID: 27693677
[TBL] [Abstract][Full Text] [Related]
7. Glyceryl ester surfactants: Promising excipients to enhance the cell permeating properties of SEDDS.
Zahir-Jouzdani F; Lupo N; Hermann M; Prüfert F; Atyabi F; Bernkop Schnürch A
Eur J Pharm Biopharm; 2018 Aug; 129():154-161. PubMed ID: 29852274
[TBL] [Abstract][Full Text] [Related]
8. Charge reversal self-emulsifying drug delivery systems: A comparative study among various phosphorylated surfactants.
Akkuş-Dağdeviren ZB; Wolf JD; Kurpiers M; Shahzadi I; Steinbring C; Bernkop-Schnürch A
J Colloid Interface Sci; 2021 May; 589():532-544. PubMed ID: 33493863
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant.
Bu P; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2016 Aug; 91():162-71. PubMed ID: 27328127
[TBL] [Abstract][Full Text] [Related]
10. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity.
Jain S; Jain AK; Pohekar M; Thanki K
Free Radic Biol Med; 2013 Dec; 65():117-130. PubMed ID: 23792276
[TBL] [Abstract][Full Text] [Related]
11. Zeta potential changing self-emulsifying drug delivery systems containing phosphorylated polysaccharides.
Griesser J; Burtscher S; Köllner S; Nardin I; Prüfert F; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2017 Oct; 119():264-270. PubMed ID: 28684278
[TBL] [Abstract][Full Text] [Related]
12. Development and in vitro evaluation of a self-emulsifying drug delivery system (SEDDS) for oral vancomycin administration.
Zaichik S; Steinbring C; Caliskan C; Bernkop-Schnürch A
Int J Pharm; 2019 Jan; 554():125-133. PubMed ID: 30408530
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Cytotoxicity of Self-Emulsifying Formulations Containing Long-Chain Lipids Using Caco-2 Cell Model: Superior Safety Profile Compared to Medium-Chain Lipids.
Desai HH; Bu P; Shah AV; Cheng X; Serajuddin ATM
J Pharm Sci; 2020 May; 109(5):1752-1764. PubMed ID: 32035926
[TBL] [Abstract][Full Text] [Related]
14. Replacing PEG-surfactants in self-emulsifying drug delivery systems: Surfactants with polyhydroxy head groups for advanced cytosolic drug delivery.
Friedl JD; Jörgensen AM; Nguyen Le NM; Steinbring C; Bernkop-Schnürch A
Int J Pharm; 2022 Apr; 618():121633. PubMed ID: 35304244
[TBL] [Abstract][Full Text] [Related]
15. Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery.
Zupančič O; Rohrer J; Thanh Lam H; Grießinger JA; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2017 Oct; 43(10):1694-1702. PubMed ID: 28589736
[TBL] [Abstract][Full Text] [Related]
16. [Design, optimization and quality evaluation of curcumin self-emulsifying drug delivery system (SEDDS)].
Wang YH; Wang SH; Yang RP; Ma XJ
Zhong Yao Cai; 2010 Dec; 33(12):1933-7. PubMed ID: 21548374
[TBL] [Abstract][Full Text] [Related]
17. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.
Gursoy RN; Benita S
Biomed Pharmacother; 2004 Apr; 58(3):173-82. PubMed ID: 15082340
[TBL] [Abstract][Full Text] [Related]
18. Cellular uptake of self-emulsifying drug-delivery systems: polyethylene glycol versus polyglycerol surface.
Friedl JD; Steinbring C; Zaichik S; Le NN; Bernkop-Schnürch A
Nanomedicine (Lond); 2020 Aug; 15(19):1829-1841. PubMed ID: 32781886
[No Abstract] [Full Text] [Related]
19. Interactions between human multidrug resistance related protein (MRP2; ABCC2) and excipients commonly used in self-emulsifying drug delivery systems (SEDDS).
Li L; Yi T; Lam CW
Int J Pharm; 2013 Apr; 447(1-2):192-8. PubMed ID: 23462368
[TBL] [Abstract][Full Text] [Related]
20. Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations.
Chudasama A; Patel V; Nivsarkar M; Vasu K; Shishoo C
Drug Deliv; 2015; 22(4):531-40. PubMed ID: 24601856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
